Tower Research Capital (TRC)’s Heliogen, Inc. HLGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,489
Closed -$12.8K 6384
2023
Q2
$12.8K Buy
1,489
+396
+36% +$3.63K ﹤0.01% 3839
2023
Q1
$9K Buy
1,093
+502
+85% +$7.62K ﹤0.01% 4587
2022
Q4
$14K Buy
591
+449
+316% +$20.3K ﹤0.01% 3557
2022
Q3
$9K Sell
142
-64
-31% -$5K ﹤0.01% 4728
2022
Q2
$15K Sell
206
-207
-50% -$26.9K ﹤0.01% 4110
2022
Q1
$76K Buy
+413
New +$75.4K ﹤0.01% 2400
2021
Q4
Sell
-7
Closed -$2K 6759
2021
Q3
$2K Buy
+7
New +$2.42K ﹤0.01% 5335

Other funds holding HLGN

Tower Research Capital (TRC)'s HLGN Position: Q3 2023 in Review

Tower Research Capital (TRC) sold out of Heliogen, Inc. (HLGN) in Q3 2023, closing a stake of 1,489 shares — an estimated $12.8K sold.

Tower Research Capital (TRC) first reported a position in HLGN in Q3 2021 and held it in 7 quarters. The position peaked at $76K in Q1 2022. 31 funds tracked by Wall St. Rank hold HLGN as of Q3 2023.

  • Tower Research Capital (TRC) reported no remaining Heliogen, Inc. position as of Q3 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,489 Heliogen, Inc. shares in Q3 2023, an estimated $12.8K.
  • Tower Research Capital (TRC) first reported a position in Heliogen, Inc. in Q3 2021 and held it in 7 quarters.
  • Tower Research Capital (TRC)'s Heliogen, Inc. position peaked at $76K in Q1 2022.
  • 31 funds tracked by Wall St. Rank held Heliogen, Inc. as of Q3 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2023, filed 14 Nov 2023.